Michael Berry

Chief Tech/Sci/R&D Officer at EVEREST MEDICINES LIMITED

59 year

Health Technology

Consumer Services

Michael Berry active positions

Companies	Position	Start	End
EVEREST MEDICINES LIMITED	Chief Tech/Sci/R&D Officer	14/06/2023	-

Companies	Position	Start	End
DYNAVAX TECHNOLOGIES CORPORATION	Corporate Officer/Principal	31/01/2015	31/07/2017
PORTOLA PHARMACEUTICALS, INC.	Corporate Officer/Principal	30/09/2013	31/01/2015
Novartis Vaccines & Diagnostics SL	Corporate Officer/Principal	31/03/2010	31/08/2013
ARCA BIOPHARMA, INC.	Director/Board Member	31/03/2005	30/04/2009
CLOVER BIOPHARMACEUTICALS, LTD.	Chief Tech/Sci/R&D Officer	14/03/2021	-

The University of Manchester	Graduate Degree
University of Manitoba	Doctorate Degree
De Montfort University	Undergraduate Degree

International

Operational

Corporate Officer/Principal	3
Chief Tech/Sci/R&D Officer	2
Director/Board Member	1

Sectoral

Health Technology	6
Consumer Services	4

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	4
DYNAVAX TECHNOLOGIES CORPORATION	Health Technology
ARCA BIOPHARMA, INC.	Health Technology
EVEREST MEDICINES LIMITED	Health Technology
CLOVER BIOPHARMACEUTICALS, LTD.	Health Technology

Private companies	2
Portola Pharmaceuticals LLC Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.	Health Technology
Novartis Vaccines & Diagnostics SL

Private companies

Health Technology

Novartis Vaccines & Diagnostics SL